Tralokinumab for Dupilumab Failures

Clinical trial NCT06773455 · TERMINATED

Trial details

NCT number: NCT06773455
Sponsor: Psoriasis Treatment Center of Central New Jersey
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2023-09-11
Primary completion: 2026-01-13
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.